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ABSTRACT
Objectives To determine the diagnostic accuracy of
duplex ultrasonography, magnetic resonance
angiography, and computed tomography angiography,
alone or in combination, for the assessment of lower limb
peripheral arterial disease; to evaluate the impact of
these assessment methods on management of patients
and outcomes; and to evaluate the evidence regarding
attitudes of patients to these technologies and
summarise available data on adverse events.
Design Systematic review.
Methods Searches of 11 electronic databases (to April
2005), six journals, and reference lists of included papers
for relevant studies. Two reviewers independently
selected studies, extracted data, and assessed quality.
Diagnostic accuracy studies were assessed for quality
with the QUADAS checklist.
Results 107 studies met the inclusion criteria; 58 studies
provided data on diagnostic accuracy, one on outcomes
in patients, four on attitudes of patients, and 44 on
adverse events. Quality assessment highlighted
limitations in the methods and quality of reporting. Most
of the included studies reported results by arterial
segment, rather than by limbor by patient, which does not
account for the clustering of segments within patients, so
specificities may be overstated. For the detection of
stenosis of 50% or more in a lower limb vessel, contrast
enhanced magnetic resonance angiography had the
highest diagnostic accuracy with a median sensitivity of
95% (range 92-99.5%) and median specificity of 97%
(64-99%). The results were 91% (89-99%) and 91% (83-
97%) for computed tomography angiography and 88%
(80-98%) and 96% (89-99%) for duplex ultrasonography.
A controlled trial reported no significant differences in
outcomes in patients after treatment plans based on
duplex ultrasonography alone or conventional contrast
angiography alone, though in 22% of patients
supplementary contrast angiography was needed to form
a treatment plan. The limited evidence available
suggested that patients preferred magnetic resonance
angiography (with or without contrast) to contrast
angiography, with half expressing no preference between
magnetic resonance angiography or duplex
ultrasonography (among patients with no
contraindications for magnetic resonance angiography,
such as claustrophobia). Where data on adverse events
were available, magnetic resonance angiography was
associated with the highest proportion of adverse events,
but these were mild. The most severe adverse events,
although rare, were mainly associated with contrast
angiography.
Conclusions Contrast enhanced magnetic resonance
angiography seems to be more specific than computed
tomography angiography (that is, better at ruling out
stenosis over 50%) and more sensitive than duplex
ultrasonography (that is, better at ruling in stenosis over
50%) and was generally preferred by patients over
contrast angiography. Computed tomography
angiography was also preferred by patients over contrast
angiography; no data on patients’ preference between
duplex ultrasonography and contrast angiography were
available. Where available, contrast enhanced magnetic
resonance angiography might be a viable alternative to
contrast angiography.
INTRODUCTION
Lower limb peripheral arterial disease is the atheroma-
tous narrowingor occlusionof an artery or arteries of the
leg. If symptoms occur these may include intermittent
claudication, ischaemic rest pain, ulceration, and
gangrene.1 Risk factors include advanced age, smoking,
hypertension, hyperlipidaemia, diabetes, obesity, and
family history.2 Management strategies differ for
patients with intermittent claudication (often conserva-
tive management, with radiological or surgical inter-
vention reserved for patients with reduced quality of
life) and patients with limb threatening ischaemia, in
whom angioplasty, surgical revascularisation, or ampu-
tationareusually required.3The choiceof intervention is
governed by the severity of the disease andmay involve
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combined treatments. Thus patients with limb threaten-
ing ischaemia require a detailed assessment for a suitable
treatment plan to be developed.
Intra-arterial contrast angiography is regarded as the
reference standard. The drawbacks are those asso-
ciated with arterial puncture, ionising radiation, and
potential nephrotoxicity of iodinated contrast agents.
Several alternative imaging techniques are available,
includingmagnetic resonance angiography, computed
tomography angiography and duplex ultrasonogra-
phy. These techniques are less invasive than contrast
angiography, although computed tomography angio-
graphy carries risks relating to ionising radiation, and
both contrast enhanced magnetic resonance angiogra-
phy and computed tomography angiography carry
risks associated with the use of contrast agents.
We carried out a systematic review to examine the
evidence regarding the performance of magnetic reso-
nance angiography, computed tomography angiogra-
phy, and duplex ultrasonography as alternatives to
contrast angiography to try to identify a technique
that is safer and more acceptable to patients but as
effective as contrast angiography for the assessment
of symptomatic peripheral arterial disease. Here we
present the systematic review of the evidence on effec-
tiveness. The full report with economic evaluation is
available elsewhere.4
METHODS
We searched 11 databases (Medline, Embase, BIOS
IS Previews, Science Citation Index, NTIS Database,
LILACS, SIGLE (system for information on grey lit-
erature in Europe), Dissertation Abstracts Online,
Inside Conferences, Pascal from 1996 to April 2005,
and the Cochrane Database of Systematic Reviews,
Issue 3, 2005), six key journals on imaging andvascular
disease, and reference lists of included studies for pub-
lished and unpublished data. No language restrictions
were applied. Electronic searches were not limited by
study design. Two reviewers conducted each stage of
the review process (except in the case of foreign lan-
guage studies), with disagreements resolved by con-
sensus or referral to a third reviewer. Full details of
the review methods, including the search strategies,
are described elsewhere.4 Table 1 presents the inclu-
sion criteria for each section of the review.
Weused theQUADASchecklist to assess the quality
of diagnostic accuracy studies.5 The results of diagnos-
tic accuracy studies were analysed according to the
imaging tests assessed (magnetic resonance angiogra-
phy, computed tomography angiography, or duplex
ultrasonography). Magnetic resonance angiography
technologies were further grouped by specific techni-
que (2D phase contrast, 2D time of flight, or contrast
enhanced). We derived the sensitivity and specificity
for the detection of stenosis in arterial segments from
the 2×2 tables reported in each study. To account for
values of zero in the 2×2 tables, we added 0.5 to all
cells.6 Heterogeneity was assessed with the Q statistic
Table 1 | Inclusion criteria for each of four sections of reviewof duplex ultrasonography,magnetic resonance angiography, and
computed tomography angiography for assessment of patientswith lower limbperipheral arterial disease
Diagnostic accuracy
Impact on patient
management/outcome Acceptability for patients Adverse events
Study design Diagnostic cohort or case-
control
Randomised controlled trial/
controlled clinical trial
Studies of any design,
excluding case reports
Studies of any design,
excluding case reports
Population Studies in ≥20 adults (≥
18 years) with symptoms
indicating lower limb
peripheral arterial disease
Studies in ≥20 adults (≥
18 years) with symptoms
indicating lower limb
peripheral arterial disease
Studies in ≥20 adults (≥
18 years) with symptoms
indicating lower limb
peripheral arterial disease
Studies in adults with
symptoms indicating lower
limb peripheral arterial disease
Index tests/
interventions
Duplex ultrasonography,
magnetic resonance
angiography, or computed
tomography angiography,
alone or in combination
Duplex ultrasonography,
magnetic resonance
angiography, or computed
tomography angiography,
alone or in combination
Duplex ultrasonography,
magnetic resonance
angiography, or computed
tomography angiography,
alone or in combination
Duplex ultrasonography,
magnetic resonance
angiography, or computed
tomography angiography,
alone or in combination
Referencestandard Intra-arterial contrast
angiography or findings at
surgery/follow-up
NA NA NA
Outcomemeasures Sufficient information to
construct 2×2 tables of test
performance
Any treatment decision or long
term outcome measure (for
example, graft/vessel patency
after intervention, morbidity)
Any reportedcriteria relating to
acceptability for patients
Adverseevents relating to index
testortocurrentlyusedcontrast
agents
NA=not applicable.
Titles and abstracts identified and screened (n=8590)
Potentially relevant papers ordered (n=650)
Not relevant (n=7940)
Total number of included studies (n=107):
  Diagnostic accuracy (n=58) 
  Management of patients  (n=1)
  Patients' attitudes (n=4) 
  Adverse events only (n=44)
Excluded (n=540)
Full copies retrieved and screened for inclusion (n=647)
Could not be obtained (n=3)
Fig 1 | Flow chart of studies through review process
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and graphically with forest plots. Most studies pro-
vided data for more than one anatomical area (above
knee, below knee, foot) or more than one threshold of
stenosis (50%, 70%, occlusion). The number of arterial
segments assessed per patient and their anatomical dis-
tribution varied and was sometimes incompletely
reported. Analyses were conducted with Meta-DiSc.7
We have presented a narrative synthesis for studies
evaluating the impact of the method of assessment on
management and outcome in patients, attitudes of
patients, and studies of adverse events.
RESULTS
The search strategy generated 8590 references, of
which 650 were considered to be potentially relevant;
ultimately 107 met the inclusion criteria. Figure 1
shows the flowof studies through the selection process.
Quality of diagnostic accuracy studies
All included studies were diagnostic cohorts and were
conducted in secondary or tertiary care settings. There
were several potential sources of bias. Spectrum bias
may have been present; over 70% of studies did not
include an appropriate range of patients (defined as
unselected, prospective adult patients with symptoms
indicating lower limb peripheral arterial disease) or
failed to provide sufficient details of the population;
48% of magnetic resonance angiography studies, 29%
of computed tomography angiography studies, and
57%of duplexultrasonography studies didnot provide
adequate details of selection criteria. Spectrum bias
may underestimate or overestimate the accuracy of a
test by investigating a selected population with regard
to the severity of disease, demographics, or
comorbidity.5 Bias may occur when the delay between
the index test and reference standard are long enough
for the disease to have progressed naturally; 20% of
magnetic resonance angiography studies, 29% of com-
puted tomography angiography studies, and 36% of
duplex ultrasonography studies did not report having
less than a one month interval between the index test
and reference standard. Bias may also occur when the
Table 2 | Diagnostic accuracy for detection of stenosis 50%ormore or occlusionwith different assessmentmethods
Study
No of
patients
Fontaine stage
II/III/IV* (%)
No of
segments
Positive
result
Negative
result Sensitivity (%) (95%
CI)
Specificity (%) (95%
CI)True False False True
Contrast enhanced magnetic resonance angiography
Cronbergw13 35 9/3/89 418 227 62 20 109 91.9 (87.8 to 95.0) 63.7 (56.1 to 70.9)
Laissyw16 20 100/0/0 520 104 14 9 393 92.0 (85.4 to 96.3) 96.6 (94.3 to 98.1)
Lenhartw17 45 NR 220 79 8 4 129 95.2 (88.1 to 98.7) 94.2 (88.8 to 97.4)
Schaferw19 30 NR 576 138 13 9 416 93.9 (88.7 to 97.2) 97.0 (94.9 to 98.4)
Steffensw21 50 NR 900 185 8 1 706 99.5 (97.0 to 100) 98.9 (97.8 to 99.5)
Sueyoshiw22 23 83/17/0 423 67 3 2 351 97.1 (89.9 to 99.6) 99.2 (97.5 to 99.8)
Wintererw23 76 87/13/0 1780 362 43 14 1361 96.3 (93.8 to 97.9) 96.9 (95.9 to 97.8)
2D time of flight magnetic resonance angiography
Baumw2 155 NR 1188 527 101 100 460 84.1 (80.9 to 86.8) 82.0 (78.6 to 85.1)
Hochw6 20 NR 544 161 37 44 302 78.5 (72.3 to 84.0) 89.1 (85.3 to 92.2)
Hochw7 45 18/20/62 352 172 13 12 155 93.5 (88.9 to 96.6) 92.3 (87.1 to 95.8)
Snidoww10 42 NR 378 80 76 7 215 92.0 (84.1 to 96.7) 73.9 (68.4 to 78.8)
Yucelw12 25 0/84/16 206 65 16 6 119 91.5 (82.5 to 96.8) 88.1 (81.5 to 93.1)
2D phase contrast magnetic resonance angiography
Steffensw1 115 100/0/0 253 229 5 5 14 97.9 (95.1 to 99.3) 73.7 (48.8 to 90.9)
Computed tomography angiography
Heuschmidw27 23 78/13/9 568 133 40 16 379 89.3 (83.1 to 93.7) 90.5 (87.2 to 93.1)
Martinw28 41 NR 1312 327 61 38 886 89.6 (86.0 to 92.5) 93.6 (91.8 to 95.0)
Pulsw30 31 97/3/0 186 56 17 7 106 88.9 (78.4 to 95.4) 86.2 (78.8 to 91.7)
Riekerw31 50 74/12/14 327 111 20 3 193 97.4 (92.5 to 99.5) 90.6 (85.9 to 94.2)
Catalanow26 50 6/48/46 1137 251 23 3 860 98.8 (96.6 to 99.8) 97.4 (96.1 to 98.3)
Portugallerw29 50 62/4/34 740 240 80 21 399 92.0 (88.0 to 95.0) 83.3 (79.7 to 86.5)
Duplex ultrasonography
Alyw33 90 90/9/1 3108 404 27 34 2643 92.2 (89.3 to 94.6) 99.0 (98.5 to 99.3)
Bergaminiw35 44 NR 404 94 13 24 273 79.7 (71.3 to 86.5) 95.5 (92.4 to 97.6)
Hatsukamiw40 29 NR 243 73 6 12 152 85.9 (76.6 to 92.5) 96.2 (91.9 to 98.6)
Linkew48 25 100/0/0 134 41 4 2 87 95.3 (84.2 to 99.4) 95.6 (89.1 to 98.8)
Sensierw50 76 88/0/12 469 214 26 28 201 88.4 (83.7 to 92.2) 88.5 (83.7 to 92.4)
El-Kayaliw55 44 NR 357 123 15 3 216 97.6 (93.2 to 99.5) 93.5 (89.5 to 96.3)
Legematew58 61 80/16/3 918 179 30 33 676 84.4 (78.8 to 89.0) 95.8 (94.0 to 97.1)
NR=not reported.
*Stage II=intermittent claudication; stage III=ischaemic rest pain; stage IV=tissue loss.
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results of the index test are interpreted by someone
with prior knowledge of the results of the reference
test and vice versa. The index test results were inter-
preted without knowledge of the reference test results
in 84%ofmagnetic resonance angiography studies and
71% of duplex ultrasonography and computed tomo-
graphy angiography studies. The reference test results
were interpreted without knowledge of the index test
results in 84% of magnetic resonance angiography stu-
dies, 82% of duplex ultrasonography studies, and 71%
of computed tomography angiography studies.
There is evidence that the availability of appropriate
clinical data increases the accuracy of interpretation.8
The availability of clinical data was poorly reported,
with only one study that evaluatedmagnetic resonance
angiography and duplex ultrasonography reporting
that clinical data were available when the imaging
results were interpreted. Full details of included studies
and quality assessment are on www.york.ac.uk/inst/
crd/projects/peripheralarterialdisease.htm.
Assessment of stenosis/occlusion
Fifty eight diagnostic accuracy studies met the inclu-
sion criteria. One evaluated 2D phase contrast
magnetic resonance angiography,w1 11 evaluated 2D
time of flight magnetic resonance angiography,w2-w12
14 evaluated contrast enhanced magnetic resonance
angiography,w8 w13-w25 7 evaluated computed tomogra-
phy angiography,w26-w32 and 28 evaluated duplex
ultrasonography.w4 w8 w33-w58 No studies evaluated 3D
time of flight magnetic resonance angiography. Con-
trast angiography was the reference standard in all stu-
dies. As there was significant heterogeneity between
individual studies we did not pool data and have pre-
sented results as medians (range).
Most of the included studies reported results by
arterial segment, rather than by limb or by patient,
which does not account for the clustering of segments
within patients. Therefore, the increased number of
segments assessed is likely to increase the number of
true negative test results, and thus the specificities may
be overstated.We report results only for studies where
data were reported by arterial segment. Full diagnostic
accuracy results are available elsewhere.4
Whole leg
Table 2 shows data for detection of stenosis 50% or
more or occlusion. Figures 2 and 3 show sensitivity
and specificity data, respectively. Contrast enhanced
magnetic resonance angiography had the highest diag-
nostic accuracy (seven studiesw13 w16 w17 w19 w21-w23), with
median sensitivity 95% (range 92-99.5%) and median
specificity 97% (64-99%). One study had a low specifi-
city (64%) compared with the others; this was the only
study to include assessment of foot vessels in the
scan.w13 2D timeof flightmagnetic resonance angiogra-
phy was less accurate (five studiesw2 w6 w7 w10 w12), with
median sensitivity 92% (79-94%) and median specifi-
city 88% (74-92%). The use of time of flight magnetic
resonance angiography has largely been superseded
by contrast enhanced magnetic resonance angiogra-
phy. Only one studyw1 evaluated 2D phase contrast
magnetic resonance angiography and this reported
sensitivity and specificity of 98% and 74%, respec-
tively.
Computed tomography angiography (six
studies,w26-w31 five of which used multidetector row
computed tomography angiography) had median sen-
sitivity 91% (89-99%) and median specificity 91% (83-
97%). Duplex ultrasonography (seven
studiesw33 w35 w40 w48 w50 w55 w58) had median sensitivity
88% (80-98%) and median specificity 96% (89-99%).
The study with the lowest sensitivity (80%) was the
only study in this group with an unacceptable delay
(that is, over one month) between the index test and
reference standard.w35
Table 3 shows data for detection of occlusion. Fig-
ures 4 and 5 show sensitivity and specificity data,
respectively. Contrast enhanced magnetic resonance
angiography (six studiesw17-w19 w21-w23) had median sen-
sitivity 94% (85-100%) and median specificity 99.2%
(97-99.8%). 2D time of flight magnetic resonance
angiography (four studiesw2 w6 w7, w12) had lower sensi-
tivity; median 86% (77-100%) and comparable specifi-
city; median 97% (85-98%). Computed tomography
Contrast enhanced magnetic resonance imaging
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Laissy
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Steffens
Sueyoshi
Winterer
2D time of flight magnetic resonance imaging
Baum
Hoch
Hoch
Snidow
Yucel
2D phase contrast magnetic resonance imaging
Steffens
Computed tomography angiography
Heuschmid
Martin
Puls
Rieker
Catalano
Portugaller
Duplex ultrasonography
Aly
Bergamini
Hatsukami
Linke
Sensier
El-Kayali
Legemate
Sensitivity (95% CI)
0.92 (0.88 to 0.95)
0.92 (0.85 to 0.96)
0.95 (0.88 to 0.99)
0.94 (0.89 to 0.97)
0.99 (0.97 to 1.00)
0.97 (0.90 to 1.00)
0.96 (0.94 to 0.98)
0.84 (0.81 to 0.87)
0.79 (0.72 to 0.84)
0.93 (0.89 to 0.97)
0.92 (0.84 to 0.97)
0.92 (0.83 to 0.97)
0.98 (0.95 to 0.99)
0.89 (0.83 to 0.94)
0.90 (0.86 to 0.93)
0.89 (0.78 to 0.95)
0.97 (0.93 to 0.99)
0.99 (0.97 to 1.00)
0.92 (0.88 to 0.95)
0.92 (0.89 to 0.95)
0.80 (0.71 to 0.87)
0.86 (0.77 to 0.92)
0.95 (0.84 to 0.99)
0.88 (0.84 to 0.92)
0.98 (0.93 to 1.00)
0.84 (0.79 to 0.89)
0 0.2 0.4 0.6 0.8 1
Sensitivity
Fig 2 | Sensitivities for the detection of stenosis ≥50% or occlusion
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angiography (five studies,w26-w28 w30 w31 four of which
used multidetector row computed tomography angio-
graphy) had median sensitivity 97% (89-100%) and
median specificity 99.6% (99-100%).
Duplex ultrasonography (seven
studiesw33 w35 w40 w48 w50 w55 w58) had median sensitivity
90% (74-94%), and median specificity 99% (96-
100%). One study reported a notably low sensitivity
(74%)w48; of the three studies that reported Fontaine
classification (a system used to describe the severity
of peripheral arterial disease), this was the only study
restricted to people with Fontaine stage II (intermittent
claudication).
Above and below the knee
Some studies provided separate results on diagnostic
accuracy for arterial segments above and below the
knee. The accuracy of the different techniques was
similar for the detection of stenosis of 50% or more
above and below the knee: with contrast enhanced
magnetic resonance angiography the median sensitiv-
ity and specificity were 87% and 93%, respectively,
above the kneew8 w14 w17 w20 and 83% and 92%below the
kneew15 w17 w24; with duplex ultrasonography the
median sensitivity and specificity were 88% and 95%
above the kneew8 w35 w39 w40 w47 w55 w56 and 84% and 93%
below the knee.w35 w40 w43 w55
Two studies assessed accuracy for the detection of
occlusion in the foot: one evaluated 2D time of flight
magnetic resonance angiographyw5 and the other con-
trast enhanced magnetic resonance angiography.w24
Sensitivities were 86% and 79%, respectively, and spe-
cificities 27% and 86%, respectively. One study
assessed the accuracy of duplex ultrasonography for
detecting target vessels suitable for surgery in the
foot, with sensitivity and specificity of 64% and 80%
respectively.w42 Although there was limited evidence,
these data suggest that these techniques may be less
accurate in the foot.
Impact of method of assessment on management and
outcome
Only one controlled trial, a prospective assessment of
duplex ultrasonography using a historical control
group, met the inclusion criteria for assessing the
impact of the assessment method on patients’manage-
ment and outcome.w59 The study included consecutive
patients with lower leg ischaemia whose treatment
plans were based on the results of either duplex ultra-
sonography with contrast angiography where indi-
cated (114 patients) or contrast angiography (control
group 113 patients).
In 78% of cases the management plan was based on
duplex ultrasonography without the need for contrast
angiography. There were no significant differences
between the groups in terms of immediate and inter-
mediate outcomes. This trial seems to have been well
conducted and the results are likely to be reliable. As it
used a historical control group, however, other factors
occurring within the timeframe of the trial may have
affected the results. Treatment and characteristics of
patients were not significantly different between the
two groups, although the authors did not comment
on some factors that could have influenced outcomes,
such as the graft material used, continuation of smok-
ing, and the use of antiplatelet drugs.
Patients’ attitudes
Four studies reported results relating to patients’ atti-
tudes. Two evaluated magnetic resonance angiogra-
phy and contrast angiography,w60 w61 one duplex
ultrasonography and magnetic resonance
angiography,w62 and one computed tomography
angiography, magnetic resonance angiography, and
contrast angiography.w63 Significantly more patients
(28/30 patients) stated that they would prefer contrast
enhanced magnetic resonance angiography over con-
trast angiography if they had to undergo testing again
in the future,w60 and contrast enhanced magnetic reso-
nance angiography scored significantly better on a
scale that rated patients’ experience of the test com-
pared with contrast angiography (P=0.0001 and P=
0.0002).w60 w61
Contrast angiography was reported as the most
uncomfortable, followed by contrast enhanced
Contrast enhanced magnetic resonance imaging
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Computed tomography angiography
Heuschmid
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Rieker
Catalano
Portugaller
Duplex ultrasonography
Aly
Bergamini
Hatsukami
Linke
Sensier
El-Kayali
Legemate
Specificity (95% CI)
0.64 (0.56 to 0.71)
0.97 (0.94 to 0.98)
0.94 (0.89 to 0.97)
0.97 (0.95 to 0.98)
0.99 (0.98 to 1.00)
0.99 (0.98 to 1.00)
0.97 (0.96 to 0.98)
0.82 (0.79 to 0.85)
0.89 (0.85 to 0.92)
0.92 (0.87 to 0.96)
0.74 (0.68 to 0.79)
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0.90 (0.87 to 0.93)
0.94 (0.92 to 0.95)
0.86 (0.79 to 0.92)
0.91 (0.86 to 0.94)
0.97 (0.96 to 0.98)
0.83 (0.80 to 0.87)
0.99 (0.99 to 0.99)
0.95 (0.92 to 0.98)
0.96 (0.92 to 0.99)
0.96 (0.89 to 0.99)
0.89 (0.84 to 0.92)
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Fig 3 | Specificities for the detection of stenosis ≥50% or occlusion
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magnetic resonance angiography, with computed
tomography angiography being the least uncomforta-
ble (P=0.016).w63 Fifty per cent of patients (who were
not claustrophobic and had no metallic implants) had
no preference between time of flight magnetic reso-
nance angiography or duplex ultrasonography (49/
98 patients). Of those who did express a preference,
most preferred time of flight magnetic resonance
angiography (40/49 patients).w62
Within the same population there was no significant
difference between time of flight magnetic resonance
angiography and duplex ultrasonography on a scale
that rated how “bothersome” the tests were.w62 While
some of the surveys potentially suffered from recall or
sequential bias, they were generally well conducted
and the results are probably reliable. As the studies
included only patients who were suitable for magnetic
resonance angiography, the results cannot be general-
ised to patients who are not suitable for magnetic reso-
nance angiography, such as those with claustrophobia
or metallic implants.
Adverse events
Nine of the diagnostic accuracy
studies,w4-w7 w19 w28 w29 w32 w37 two studies reporting
patient attitudes,w60 w62 and 44 additional studies,
w64-w107 reported results relating to adverse events.
The lack of reporting of data on adverse events cannot
be interpreted as no adverse events having occurred.
The criteria used in monitoring and recording adverse
events varied and were not always reported. These
results should therefore be regarded only as a guide
to the spectrum of adverse events reported and not as
an accurate assessment of their frequency.
The most commonly reported adverse events were
minor pain or discomfort during or immediately after
the procedure (17% for 2D time of flightmagnetic reso-
nance angiography (2/12 patients), 22% for duplex
ultrasonography (22/98 patients), and up to 10% for
contrast enhanced magnetic resonance angiography
(10/98 patients)), acute symptoms in the digestive sys-
tem associated with contrast enhanced magnetic reso-
nance angiography (up to 10% (2/20) patients), anxiety
associated with 2D time of flight magnetic resonance
angiography (10% (4/40) patients), and acute adverse
events in the central and peripheral nervous system
associated with contrast enhancedmagnetic resonance
angiography (up to 10% (2/20) patients).
The highest proportion of adverse events was
reported for magnetic resonance angiography. Major
adverse events (death and severe vascular adverse
events), however,were reported in a higher proportion
Table 3 | Diagnostic accuracy for detection of occlusionwith different assessmentmethods
Study
No of
patients
Fontaine stage
II/III/IV* (%)
No of
segments
Positive
result
Negative
result Sensitivity (%) (95%
CI)
Specificity (%) (95%
CI)True False False True
Contrast enhanced magnetic resonance angiography
Lenhartw17 45 NR 220 54 2 4 160 93.1 (83.3 to 98.1) 98.8 (95.6 to 99.9)
Meaneyw18 20 100/0/0 630 83 16 15 516 84.7 (76.0 to 91.2) 97.0 (95.2 to 98.3)
Schaferw19 30 NR 576 72 1 5 498 93.5 (85.5 to 97.9) 99.8 (98.9 to 100)
Steffensw21 50 NR 900 85 7 4 804 95.5 (88.9 to 98.8) 99.1 (98.2 to 99.7)
Sueyoshiw22 23 83/17/0 423 39 1 0 383 100 (91.0 to 100) 99.7 (98.6 to 100)
Wintererw23 76 87/13/0 1780 255 11 13 1501 95.1 (91.8 to 97.4) 99.3 (98.7 to 99.6)
2D time of flight magnetic resonance angiography
Baumw2 155 NR 1188 322 118 76 672 80.9 (76.7 to 84.6) 85.1 (82.4 to 87.5)
Hochw6 20 NR 544 103 17 31 393 76.9 (68.8 to 83.7) 95.9 (93.4 to 97.6)
Hochw7 45 18/20/62 352 101 4 11 236 90.2 (83.1 to 95.0) 98.3 (95.8 to 99.5)
Yucelw12 25 0/84/16 206 40 4 0 162 100 (91.2 to 100) 97.6 (93.9 to 99.3)
Computed tomography angiography
Heuschmidw27 23 78/13/9 568 49 6 5 508 90.7 (79.7 to 96.9) 98.8 (97.5 to 99.6)
Martinw28 41 NR 1312 202 2 26 1082 88.6 (83.7 to 92.4) 99.8 (99.3 to 100)
Pulsw30 31 97/3/0 186 13 0 0 173 100 (75.3 to 100) 100 (97.9 to 100)
Riekerw31 50 74/12/14 327 61 1 1 264 98.4 (91.3 to 100) 99.6 (97.9 to 100)
Catalanow26 50 6/48/46 1137 170 5 5 957 97.1 (93.5 to 99.1) 99.5 (98.8 to 99.8)
Duplex ultrasonography
Alyw33 90 90/9/1 3108 272 18 25 2793 91.6 (87.8 to 94.5) 99.4 (99.0 to 99.6)
Bergaminiw35 44 NR 404 76 10 13 305 85.4 (76.3 to 92.0) 96.8 (94.2 to 98.5)
Hatsukamiw40 29 NR 233 51 3 6 173 89.5 (78.5 to 96.0) 98.3 (95.1 to 99.6)
Linkew48 25 100/0/0 134 14 0 5 115 73.7 (48.8 to 90.9) 100 (96.8 to 100)
Sensierw50 76 88/0/12 469 166 11 21 271 88.8 (83.3 to 92.9) 96.1 (93.1 to 98.0)
Zeuchnerw53 54 NR 322 50 3 3 266 94.3 (84.3 to 98.8) 98.9 (96.8 to 99.8)
Legematew58 61 80/16/3 918 103 6 9 800 92.0 (85.3 to 96.3) 99.3 (98.4 to 99.7)
NR=not reported.
*Stage II=intermittent claudication; stage III=ischaemic rest pain; stage IV=tissue loss.
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of patients who underwent contrast angiography,
although the overall proportion who experienced
major adverse events was low (severe vascular adverse
events: contrast angiography 5% (1/19 patients); con-
trast enhanced magnetic resonance angiography 0.5%
(2/435 patients)). Therewere twodeaths: onewith con-
trast angiography and one with contrast enhanced
magnetic resonance angiography.
Studies reported adverse events related to the con-
trast agent for a small proportion of patients in relation
to contrast angiography (acute renal failure in 10% (4/
42) of patients with baseline chronic renal insuffi-
ciency) and contrast enhanced magnetic resonance
angiography (acute renal failure: 1% (3/218) of patients
with baseline chronic renal insufficiency; acute change
in renal function: 1% (2/136 patients); severe unspeci-
fied adverse events related to contrast agent: up to 1%
(5/641 patients)). In one study, which was specifically
designed to evaluate the dose response and safety of
one contrast agent (gadofosveset trisodium),w83 a high
proportion of patients (25%; 59/238) experienced
unspecified adverse events related to the contrast
agent after contrast enhanced magnetic resonance
angiography.
DISCUSSION
Key findings
Contrast enhancedmagnetic resonance angiography is
the most accurate diagnostic technique for the
detection of (50% or more) stenosis or occlusion, with
most studies reporting sensitivities and specificities of
over 90% (based on a “per segment” rather than “per
patient” analysis). Magnetic resonance angiography
was associated with the highest proportion of adverse
events, although these were generally mild, with the
most severe events associated with contrast angiogra-
phy. The results of three surveys on patients’ attitudes
showed that patients who had no contraindications for
magnetic resonance angiography preferred magnetic
resonance angiography to contrast angiography.
The use of computed tomography angiography for
the assessment of peripheral arterial disease is a rela-
tively recent development, and its contribution to
effective surgical planning remains to be explored.
Patients found computed tomography angiography
less uncomfortable than contrast angiography or mag-
netic resonance angiography, and only a few mild
adverse events were reported.
The only controlled trial of the effectiveness of ima-
ging procedures, in terms of surgical planning and out-
come of patients, found that duplex ultrasonography
and contrast angiography were comparable, a result
that is seemingly at odds with poor estimates of the
diagnostic accuracy for duplex ultrasonography. The
sensitivity of duplex ultrasonography seems to be
inferior to both contrast enhancedmagnetic resonance
angiography and computed tomography angiography,
which means that duplex ultrasonography may miss
some significant stenoses. This may be of particular
concern if duplex ultrasonography were to be used to
screen patients before surgical planning. Duplex ultra-
sonography, however, is unlikely to misclassify a
whole limb as “normal” and thus inappropriately
screen out a patient from further investigation. Fifty
per cent of patients expressed no preference between
time of flight magnetic resonance angiography or
duplex ultrasonography, and those who did generally
preferred time of flight magnetic resonance angiogra-
phy.We had no data on patients’ preferences between
contrast enhanced magnetic resonance angiography
and duplex ultrasonography. Some studies reported
minor adverse events associated with duplex ultraso-
nography—namely, anxiety or minor pain or discom-
fort during or immediately after the procedure.
The area of leg assessed probably affects diagnostic
performance. Contrast enhanced magnetic resonance
angiography and duplex ultrasonography were less
accurate for detecting stenoses in the foot. There was
insufficient evidence to judge computed tomography
angiography. The assessment of potential outflow ves-
sels in the foot is known to be problematic9 and war-
rants further research, particularly with respect to
newer technologies such as computed tomography
angiography. Separate data on calf vessels and foot ves-
sels are required as the inclusion of foot vessels in
below knee imagingmay lower the accuracy of results.
Strengths and weaknesses of the review
We conducted extensive literature searches to locate
all relevant studies. The possibility of publication bias
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Fig 4 | Sensitivities for the detection of occlusion
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remains a potential problem for all systematic reviews.
The extent to which publication bias is an issue for
diagnostic studies remains unclear as such studiesmea-
sure the agreement between the results of the index test
and the reference standard, rather than assessing
whether there is a significant difference in outcome
between an intervention and control group. Studies
reporting higher estimates of test performance are
more likely to be published, but the extent to which
this occurs is unclear. Similarly, tests might not per-
form as well in the clinical setting as indicated by
reports from research studies.
Our review was limited by the lack of high quality,
well reported studies. We found only one controlled
trial, which used a historical control group that could
be subject to bias. Most studies that provided data on
diagnostic accuracy had small sample sizes (median
41.5, range 20-183) and reported results on a per seg-
ment rather than per patient basis. Our review there-
fore provides information on the ability of these
techniques to detect stenosis within particular arterial
segments but not for determining the presence or
absence of disease on a per patient or per limb basis.
Few included studies reported these data. Analysis by
segment also means that the estimates of the 95% con-
fidence intervals for sensitivity and specificity do not
account for the clustering of segments within patients.
This would also affect statistical testing of heterogene-
ity, but given the considerable heterogeneity observed,
any conclusions are not likely to be affected. The esti-
mates of specificity derived from this type of studymay
be raised as increasing the number of segments
assessed is likely to increase the number of true nega-
tives.
Wedid not collect data on variability between obser-
vers, although we note that the methods used to ascer-
tain degree of stenosis were not generallywell reported
and few studies directly measured such variability.
This is an important issue in the evaluation of tests
that require subjective interpretation,10 and further
investigation of its effects on estimates of the accuracy
of vascular imaging techniques is needed.
The field of vascular imaging research is evolving
rapidly, particularly in relation to the use of computed
tomography angiography, which is a relatively recent
development in the assessment of peripheral arterial
disease. We did not find any study investigating the
diagnostic accuracy of the new 64 slice computed
tomography angiography as this is a very new devel-
opment. Our results represent the imaging techniques
available at the time the primary studies were under-
taken and will become out of date as new techniques
emerge.
Implications for clinical practice
From data that reported the accuracy of the imaging
tests at assessing arterial segments, rather than the
whole limb or areas of the limb, contrast enhanced
magnetic resonance angiography seemed to have bet-
ter overall diagnostic accuracy than computed tomo-
graphy angiography and duplex ultrasonography, and
was preferred by patients over conventional angiogra-
phy. It might therefore be a viable alternative to con-
ventional contrast angiography for assessing patients
with peripheral arterial disease before treatment. We
could not identify enough data to assess the effective-
ness of the imaging tests in terms of surgical planning
and postoperative outcomes. In addition, the lack of
data on severity of disease and comorbidities reported
by the included studies reduces the generalisability of
these findings.
Implications for further research
Quality assessment highlighted limitations in the qual-
ity ofmethods and reporting ofmany included studies.
Future evaluations of diagnostic tests should follow the
STARD guidelines for reporting of diagnostic accu-
racy studies.11 12 They should also consider reporting
results by patient or by limb, as well as by segment, if
they would be relevant to clinical practice.
Further research should assess the performance and
adverse effects of the imaging tests on different sub-
groups of patients, particularly those who may be at
higher risk of certain adverse events, such as those
with diabetes and renal insufficiency. Additional sepa-
rate data are required regarding the performance of the
different imaging tests for assessing calf and foot ves-
sels. The use of newer technologies, such as computed
tomography angiography, for the assessment of per-
ipheral arterial disease should be assessed.
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Data on the influence of imaging technologies on the
surgical planning and postoperative outcome for
patients with peripheral arterial disease are urgently
needed.A simple comparison of the accuracy of a tech-
nique for defining the degree of stenosis cannot fully
assess the ability of a procedure to produce the “vascu-
lar roadmap” as factors such as length and grouping of
stenoses are not considered. In addition a comparative
diagnostic accuracy study assumes that the result of the
reference standard investigation (in this case contrast
angiography) is always correct. Therefore, an evalua-
tion with this method can never find that the new tech-
nology (index test) gives superior information to that
provided by current practice (reference standard).
The most reliable and appropriate method for
obtaining comparative data on different testing options
would be a randomised controlled trial designed to
provide information on the influence of tests on deci-
sions about treatment and outcomes in patients with
peripheral arterial disease. Data on health economics
could be collected simultaneously. There may be ethi-
cal objections to a randomised controlled trial, such as
the withholding of an available test, particularly when
it is a routine part of assessment of peripheral arterial
disease in the institution involved in the study. Such a
trial would be difficult because of the refinements in
technology over time, the availability of the technolo-
gies, and the potentially large sample size required. A
large multicentre trial might be necessary.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Severity of diseasedetermines themanagement strategy for
symptomatic lower limb peripheral arterial disease, so
detailed assessment of patients is neededbefore a suitable
treatment plan can be developed
Intra-arterial contrast angiography is regarded as the
reference standard investigation for the assessment of
peripheral arterial disease
WHAT THIS STUDY ADDS
Contrast enhanced magnetic resonance angiography has
better overall diagnostic accuracy than computed
tomography angiography or duplex ultrasonography and is
generally preferred by patients over conventional contrast
angiography
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